Epidemiological profile of COVID-19 in patients with prostate cancer undergoing androgen deprivation therapy at a Brazilian Cancer Center.

Isabela Granato Travalini Lucas Bonachi Vergamini Ivan Leonardo Avelino França E Silva Pedro Caruso Fernanda Monteiro Orellana Maria Paula Curado Stenio de Cassio Zequi

Published in: Einstein (Sao Paulo, Brazil) (2023)

Androgen deprivation therapy was not associated with protective factors or potential treatments in patients with prostate cancer and COVID-19. Although the number of patients analyzed was limited, and there may have been a selection bias, this is a unique study that cannot be expanded or replicated in similar (unvaccinated) populations.

Keyphrases

prostate cancer
coronavirus disease
sars cov
radical prostatectomy
end stage renal disease
ejection fraction
newly diagnosed
squamous cell
squamous cell carcinoma
mesenchymal stem cells
respiratory syndrome coronavirus
climate change
human health
smoking cessation
patient reported